Synchrony Labs
Private Company
Total funding raised: $3.2M
Overview
Synchrony Labs is a specialized preclinical contract research organization (CRO) with a 40+ year legacy originating from cardiology leaders at Duke University. The company operates state-of-the-art laboratories in North Carolina's Research Triangle, offering end-to-end services including study design, protocol development, device implantation, and regulatory reporting for medical device and biopharma clients. Its core value proposition is providing flexible, deadline-driven, and GLP-compliant testing with a team of seasoned veterinarians, physicians, and data scientists to de-risk and advance novel medical technologies. While positioned in the Digital Health/AI sector, its current operations are firmly centered on expert preclinical services rather than developing its own therapeutic or diagnostic products.
Technology Platform
Integrated preclinical service platform featuring GLP-compliant laboratories, specialized surgical suites for large animal models, and a team of expert veterinarians and physicians. Expertise is the core platform, not a licensable technology.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competes in the preclinical CRO market against large, diversified players (e.g., Charles River, Labcorp) and smaller specialty labs. Its differentiation is based on deep, hands-on expertise in complex surgical models (especially cardiovascular), a team blending DVMs and MDs, and a focus on flexible, client-collaborative service rather than high-volume throughput.